Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts
- PMID: 8668847
Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts
Abstract
Cytomegalovirus (CMV) is capable of establishing persistent or latent infection after primary infections and reactivation in immunocompromised hosts. The understanding of the nature of this latency is incomplete. The acquisition of CMV-specific immune responses appears essential for limiting primary infection and maintenance of a clinical state of latency. Host immunity induced by CMV infection includes both cellular and humoral responses. Cell-mediated responses by both CD4+ (T helper) and CD8+ cytotoxic T lymphocytes (CTLs) are detected in CMV-seropositive individuals. Studies in animal models and in immunocompromised patients have implicated deficiencies in class I MHC-restricted, CD8+CMV-specific CTL responses in the progression of experimental and human CMV infection and pneumonia. Adoptive transfer of CD8+CMV-specific CTLs in immunodeficient marrow transplant recipients provides evidence that adoptive immunotherapy with T-cell clones of defined specificity and function can be used to safely and successfully restore immunity to a human pathogen.
Similar articles
-
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.Haematologica. 1999 Jan;84(1):71-9. Haematologica. 1999. PMID: 10091394 Review.
-
Adoptive immunotherapy of HCMV infection.Cytotherapy. 2007;9(8):699-711. doi: 10.1080/14653240701656046. Epub 2007 Oct 4. Cytotherapy. 2007. PMID: 17917875 Review.
-
Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones.Bone Marrow Transplant. 1994;14 Suppl 4:S78-84. Bone Marrow Transplant. 1994. PMID: 7728132 Review.
-
Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.Cytometry B Clin Cytom. 2008 Jul;74(4):211-20. doi: 10.1002/cyto.b.20420. Cytometry B Clin Cytom. 2008. PMID: 18454493
-
[The role of the host's immune system in the pathogenesis of cytomegalovirus-associated disease].Nihon Rinsho. 1998 Jan;56(1):97-101. Nihon Rinsho. 1998. PMID: 9465672 Review. Japanese.
Cited by
-
Modulation of cytomegalovirus immune evasion identifies direct antigen presentation as the predominant mode of CD8 T-cell priming during immune reconstitution after hematopoietic cell transplantation.Front Immunol. 2024 Feb 15;15:1355153. doi: 10.3389/fimmu.2024.1355153. eCollection 2024. Front Immunol. 2024. PMID: 38426094 Free PMC article.
-
Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures.Thorax. 2001 May;56(5):379-87. doi: 10.1136/thorax.56.5.379. Thorax. 2001. PMID: 11312407 Free PMC article.
-
Immune surveillance of cytomegalovirus in tissues.Cell Mol Immunol. 2024 Sep;21(9):959-981. doi: 10.1038/s41423-024-01186-2. Epub 2024 Aug 12. Cell Mol Immunol. 2024. PMID: 39134803 Free PMC article. Review.
-
Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence.J Virol. 1999 Oct;73(10):8612-22. doi: 10.1128/JVI.73.10.8612-8622.1999. J Virol. 1999. PMID: 10482614 Free PMC article.
-
Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection.Med Microbiol Immunol. 2008 Jun;197(2):167-78. doi: 10.1007/s00430-008-0084-3. Epub 2008 Feb 29. Med Microbiol Immunol. 2008. PMID: 18309517 Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials